EXAGEN INC.
XGN· Nasdaq· Services-Medical Laboratories
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -21.4%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +9.7%
We record prices for the companies we cover; XGN is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 21.6M
- Revenue
- $66.6M
- Free cash flow
- -$14.3M
- Owner earnings
- -$16.4M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- 58.3%
- Operating
- -21.1%
- Net
- -30.0%
- Free cash flow
- -21.4%
- Owner earnings
- -24.7%
- Stock pay
- 3.2%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- -114.3%
- ROE, 5 yr avg
- -104.1%
Growth (CAGR)
- Revenue, 3 yr
- 13.5%
- Revenue, 5 yr
- 9.7%
- Revenue, 7 yr
- 10.8%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Diluted EPS, 7 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
- Free cash flow, 7 yr
- –
Financial health · FY2025
- Cash and investments
- $32.2M
- Total debt
- $22.9M
- Net cash
- $9.3M
- Debt/Equity
- 1.3x
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- 11.3%
Financials: ten years from the 10-Ks
Revenue
$66.6M
+10.8% a year over 7 years
FY2018FY2025
Margins
Gross58.3%Operating-21.1%Net-30.0%
FY2025
FY2018FY2025
Free cash flow and owner earnings
Free cash flow-$14.3MOwner earnings-$16.4M
FY2025
FY2018FY2025
Diluted shares
21.6M
+70.7% over 7 years, net dilution
FY2018FY2025
Net cash
$9.3M
$9.3M more cash than debt
FY2018FY2025
Every figure, year by year
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| The business | ||||||||
| Revenue | $32.4M | $40.4M | $42.0M | $48.3M | $45.6M | $52.5M | $55.6M | $66.6M |
| Revenue growth | – | 24.5% | 3.9% | 15.1% | -5.7% | 15.3% | 5.9% | 19.7% |
| Gross margin | – | – | – | – | – | 56.1% | 59.5% | 58.3% |
| Operating margin | -15.0% | -23.0% | -36.2% | -49.8% | -101.1% | -43.5% | -24.5% | -21.1% |
| Net income | -$8.0M | -$12.0M | -$16.7M | -$26.9M | -$47.4M | -$23.7M | -$15.1M | -$20.0M |
| Net margin | -24.7% | -29.8% | -39.8% | -55.6% | -104.0% | -45.1% | -27.2% | -30.0% |
| Diluted EPS | – | – | $-1.32 | $-1.68 | $-2.77 | $-1.34 | $-0.83 | $-0.93 |
| Return on invested capital? | – | – | – | – | – | – | – | – |
| Cash | ||||||||
| Operating cash flow | -$9.3M | -$9.7M | -$14.1M | -$20.3M | -$32.1M | -$14.5M | -$13.3M | -$13.6M |
| Capital expenditure | $199.0K | $403.0K | $455.0K | $2.4M | $4.3M | $828.0K | $515.0K | $641.0K |
| Free cash flow | -$9.5M | -$10.1M | -$14.5M | -$22.6M | -$36.5M | -$15.3M | -$13.8M | -$14.3M |
| Stock-based compensation | $114.0K | $572.0K | $2.7M | $4.7M | $4.7M | $3.6M | $1.8M | $2.2M |
| Owner earnings? | -$9.6M | -$10.7M | -$17.2M | -$27.4M | -$41.2M | -$18.9M | -$15.6M | -$16.4M |
| Free cash flow per share | – | – | $-1.15 | $-1.42 | $-2.13 | $-0.86 | $-0.76 | $-0.66 |
| Capital allocation | ||||||||
| Dividends paid | – | – | – | – | – | – | – | – |
| Share repurchases | – | – | – | – | – | – | – | – |
| Diluted shares | – | – | 12.6M | 16.0M | 17.1M | 17.7M | 18.2M | 21.6M |
| Share count change? | – | – | – | 26.4% | 7.0% | 3.5% | 3.0% | 18.4% |
| Balance sheet | ||||||||
| Cash and equivalents | $13.2M | $72.1M | $57.4M | $99.4M | $62.4M | $36.5M | $22.0M | $32.2M |
| Short-term investments | – | – | – | – | – | – | – | – |
| Total debt | $24.6M | $25.9M | $26.7M | $27.5M | $29.0M | $19.5M | $20.2M | $22.9M |
| Net debt | $11.5M | -$46.2M | -$30.8M | -$72.0M | -$33.4M | -$17.0M | -$1.8M | -$9.3M |
| Shareholders' equity | -$112.0M | $55.7M | $41.8M | $84.9M | $42.5M | $22.7M | $9.5M | $17.4M |
Latest filings
| 2026-08-04 | 10-Q | Quarterly report |
| 2026-08-04 | 8-K | Earnings release |
| 2026-05-11 | 10-Q | Quarterly report |
| 2026-05-11 | 8-K | Earnings release |
| 2026-04-27 | DEF 14A | Proxy statement |
| 2026-03-10 | 10-K | Annual report |
| 2026-03-10 | 8-K | Earnings release |
| 2026-01-12 | 8-K | Earnings release |
| 2025-11-04 | 10-Q | Quarterly report |
| 2025-11-04 | 8-K | Earnings release |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
